Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of ADI PEG 20 in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy

NCT01910025 is registered in ClinicalTrials.gov with Polaris Group as lead sponsor.

NCT NCT01910025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01910025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of ADI PEG 20 in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy
Lead sponsor
Polaris Group
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2013
Completion date
December 15, 2017
Enrollment
18 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin's lymphoma